weakness/1000
Instructed in new medication Prednisone and in S/E such as euphoria, insomnia, psychotic behavior, vertigo, headache, paresthesia, seizures, pseudotumor cerebri, heart failure, hypertension, edema, arrhythmias, thrombophlebitis, thromboembolism, cataracts, glaucoma, peptic ulceration, GI irritation, increased appetite, pancreatitis, nausea, vomiting, menstrual irregularities, increased urine calcium levels, hypokalemia, hyperglycemia, carbohydrate intolerance, growth suppression in children, muscle weakness, osteoporosis, hirsutism, delayed wound healing, acne and various skin eruptions.
Instructed to recognize S/S of Rheumatoid arthritis such as loss of appetite, fatigue, weakness, pain and tenderness of joint, weight loss, swelling, etc.
Instructed in new medication Temazepam to manage insomnia. In addition, warned of possible S/E such as drowsiness, dizziness, lethargy, disturbed coordination, daytime sedation, confusion, nightmares, vertigo, euphoria, weakness, headache, fatigue, nervousness, anxiety, depression, blurred vision, diarrhea, nausea, dry mouth, physical and psychological dependence. Avoid alcohol during therapy. Caution when performing activities that require mental alertness or physical coordination. Instructed not to discontinue drug abruptly if it is taken for 1 month or longer.
Instructed in new medication Amitriptyline to manage depression. In additon, warned of possible S/E such as coma, seizures, hallucinations, delusions, disorientation, ataxia, tremor, peripheral neuropathy, anxiety, insomnia, restlessness, drowsiness, dizziness, weakness, fatigue, headache, extrapyramidal reactions, MI, stroke, arrhythmias, heart block, orthostatic hypotension, tachycardia, ECG changes, hypertension, edema, blurred vision, tinnitus, mydriasis, increased intraocular pressure, dry mouth, nausea, vomiting, anorexia, epigastric distress, diarrhea, constipation, paralytic ileum, urine retention, agranulocytosis, thrombocytopenia, leukopenia, eosinophilia, hypoglycemia, hyperglycemia, rash, urticaria, photosensitivity, diaphoresis and hypersensitivity reaction. Instructed to take full dose at bedtime but warned patient of possible morning orthostatic hypotension. Avoid alcohol during drug therapy. Consult MD before taking other medications. Avoid activities that require alertness and good psychomotor coordination until CNS effects of drug are known. Drowsiness and dizziness usually subside after a few weeks. Dry mouth may be relieved with sugarless hard candy or gum. Saliva substitutes may be needed. Instructed to use a sun block, wear protective clothing and avoid prolonged exposure to strong sunlight. To prevent photosensitivity reactions. Do not stop drug therapy abruptly.
Instructed in how to recognize S/S of hypotension such as dizziness, blurred vision, fatigue, weakness, confusion, etc.
Instructed in how to recognize signs and symptoms of high blood sugar such as frequent urination, excessive thirst, headache, weakness, fatigue, dizziness, nausea, vomiting, abdominal cramps, etc.
Instructed in Vitamin B1 and in S/E such as weakness, restlessness, nauseas, uriticaria, pruritus, tenderness, and ?induration after IM administration. .
Instructed in new medication Albuterol to prevent or treat bronchospasm in patients with reversible obstructive airway disease. In addition, warned of possible S/E such as tremor, nervousness, dizziness, insomnia, headache, hyperactivity, weakness, CNS stimulation, malaise, tachycardia, palpitations, hypertension, dry and irritated nose and throat (with inhaled form), nasal congestion, epistaxis, hoarseness, heartburn, nausea, vomiting, anorexia, bad taste in mouth, increased appetite, hypokalemia, muscle cramps, bronchospasm, cough, wheezing, dyspnea, bronchitis, increased sputum or hypersensitivity reactions. Warned patient about possibility of paradoxical bronchospasm. If this occurs, discontinue drug immediately. If more than one inhalation is ordered, instructed to wait at least 2 minutes before repeating procedure. Use of an aero chamber may improve drug delivery to the lungs. If steroid inhaler used, advised to use the bronchodilator first and then advised to wait about 5 minutes before using the steroid. This allows the bronchodilator to open the air passages for maximum effectiveness. Advised to remove canister and wash inhaler with warm, soapy water at least once a week.
Instructed in possible effects of a stroke such as paralysis or weakness on one side of the body, difficulty with speech and language, urine and fecal incontinence, visual deficits, emotional lability.
Instructed in complication requiring medical intervention associated with hypertension such as SOB, blurred vision, headache and extreme weakness.